The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

Psoriasis, a chronic autoimmune disease, is most commonly associated with symptoms that affect the skin. But it can also cause persistent fatigue, sometimes so severe that it reduces your quality ...

Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...